Zhenzhou Shen
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Genetics top 10%
- Topics
- Breast Cancer Treatment Studies (23 papers)HER2/EGFR in Cancer Research (11 papers)Cancer Treatment and Pharmacology (10 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Zhenzhou Shen
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Oncology 689
- Cancer Research 574
- Molecular Biology 551
- Pathology and Forensic Medicine 249
- Genetics 204
Countries citing papers authored by Zhenzhou Shen
This map shows the geographic impact of Zhenzhou Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhou Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhou Shen more than expected).
Fields of papers citing papers by Zhenzhou Shen
This network shows the impact of papers produced by Zhenzhou Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhou Shen. The network helps show where Zhenzhou Shen may publish in the future.
Co-authorship network of co-authors of Zhenzhou Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhou Shen. A scholar is included among the top collaborators of Zhenzhou Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhou Shen. Zhenzhou Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer | 2 |
| 3 | 2 | |
| 4 | 1 | |
| 5 | [Current trends of breast reconstruction after mastectomy for breast cancer patients in China: a survey report]. | 12 |
| 6 | 23 | |
| 7 | 16 | |
| 8 | 15 | |
| 9 | 49 | |
| 10 | 120 | |
| 11 | 15 | |
| 12 | Promoter methylation and its significance of hMLH1, E-cadherin and p16~(INK4a) gene in esophageal squamous cell carcinoma | 1 |
| 13 | 10 | |
| 14 | 10 | |
| 15 | 34 | |
| 16 | 99 | |
| 17 | 5 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 9 |
About Zhenzhou Shen
Zhenzhou Shen is a scholar working on Cancer Research, Oncology and Genetics, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Cancer Research (574 citations), Molecular Medicine (168 citations) and Oncology (689 citations). Zhenzhou Shen has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Jinsong Lu, Zhi‐Ming Shao, Gen‐Hong Di, Jiong Wu, Yiwei Jiang, Wenjin Yin, Vay Liang W. Go, Canhui Liu, David Heber and Mai Nguyen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.